Impact of a Cancer Gene Variant Reclassification Program Over a 20-Year Period

PURPOSE: Hereditary cancer genetic testing can inform personalized medical management for individuals at increased cancer risk. However, many variants in cancer predisposition genes are individually rare, and traditional tools may be insufficient to evaluate pathogenicity. This analysis presents dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Esterling, Lisa, Wijayatunge, Ranjula, Brown, Krystal, Morris, Brian, Hughes, Elisha, Pruss, Dmitry, Manley, Susan, Bowles, Karla R., Ross, Theodora S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469614/
https://www.ncbi.nlm.nih.gov/pubmed/32923914
http://dx.doi.org/10.1200/PO.20.00020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469614/
https://www.ncbi.nlm.nih.gov/pubmed/32923914
http://dx.doi.org/10.1200/PO.20.00020

Ejemplares similares